Back to search
FDAFDA · Food and drugs·Recall number D-0395-2015

Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg, 90-count bottles, Rx Only, Manufactured by: Actavis Elizabeth LLC, Elizabeth, NJ 07201 USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA; NDC 45963-305-09, UPC 3 45963-305-09 1.

Published March 11, 2015 · Recall initiated: February 10, 2015

Summary

FDA records drug Class II recall D-0395-2015, published March 11, 2015 and initiated February 10, 2015. Recalling firm: Actavis Elizabeth LLC; Status: Terminated; Reported quantity: 42 bottles; Lot: Lot #: 2020E141, Exp 07/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if DEXTROAMPHETAMINE SULFATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DEXTROAMPHETAMINE SULFATE
Manufacturer
Actavis Elizabeth LLC
Distributor
Nationwide
UPC
0345963305091
Lot
Lot #: 2020E141, Exp 07/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg, 90-count bottles, Rx Only, Manufactured by: Actavis Elizabeth LLC, Elizabeth, NJ 07201 USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA; NDC 45963-305-09, UPC 3 45963-305-09 1. recalled?

Yes. FDA published recall D-0395-2015 on March 11, 2015. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DEXTROAMPHETAMINE SULFATE. UPC: 0345963305091.